Sundberg, Fawcett, Illner & McCann (1975) have shown that high concentrations of indomethacin (1 and 2\m=.\7mM) can increase the release of LH and FSH from rat pituitary tissue in vitro. Such concentrations, however, have other actions in addition to the inhibition of prostaglandin (PG) synthetase for which the drug is commonly used experimentally (Flower, 1974 during the control period appeared to be stable from experiment to experiment, and adjustment based on the relation¬ ship reduced error more effectively than simple arithmetic correction for control release. Analysis of variance allowed the removal of variation due to differences among blocks and, when the combined effects of two substances were tested, the significance of their interaction could be assessed. Variance tended to be high when mean hormone release was high (see Table 1 ), but data were not transformed because Bartlett's test showed no significant heterogeneity of variance within experiments (P > 005).
with 5 pM-indomethacin (Table 1 ; Exp. 2). The fall in LH was comparable with that in the previous experiment and was just short of significance (F = 4-35; d.f. = 1,9) .
The effect of the two concentrations of indomethacin was tested on pituitary tissue stimulated submaximally by LH-RH (Table 1 ; Exps 3 and 4). The high indomethacin concentration caused a significant increase in LH release (P < 0-05) and a nearly significant increase in FSH (P < 0-1), but the low concentration was without effect.
The reduction in LH release by 5 pM-indomethacin seems more likely to be due to P G synthetase inhibition than the increase in release seen with 200 pM, a concentration at which other effects of the drug are likely to obtrude (Flower, 1974 (Zor, Taneko, Schneider, McCann & Field, 1970; Sundberg et ai, 1975; Drouin & Labrie, 1975) : this was the case in the experiment reported below. Despite these reports, the effect of the low concentration of indomethacin suggests that PGs may exert a stimulatory effect on the small basal release of LH which occurs when pituitary glands are removed, bisected and incubated in vitro, but that this effect is negligible when the gland is under physiological stimulation.
The increase in gonadotrophin release with high concentrations of indomethacin could be due to inhibition of PG synthetase if PGs were inhibitory to hormone release in this experimental system. Table 2 indomethacin increased LH release significantly, and so did PGE-1 ( < 005), the effect of the latter being due to the higher concentration (50 pM). There was no significant interaction between the effects of PGE-1 and indomethacin (P > 0-2), suggesting that, although the increase in LH release due to the drug was slightly less in the presence of PGE-1, the difference was not significant. Release of FSH showed a similar pattern with significant effects of PGE-1 and indomethacin but there was no significant inter¬ action (P > 0-2). In a second experiment (Table 3) , PGE-2 or PGF-2ct produced non-significant increases in the release of LH and FSH (P > 0-1) while indomethacin significantly increased both.
Although there was a suggestion that the effect of indomethacin on LH release was greater in the presence of PG, there was no significant interaction (P > 0-2) between the effects of the two substances on either hormone.
